Nordea Investment Management
ARCT icon

Nordea Investment Management’s Arcturus Therapeutics ARCT Stock Holding History

Nordea Investment Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-94,419
Closed -$997K – 864
2025
Q1 		$997K Buy
94,419
+28,641
+44% +$455K ﹤0.01% 812
2024
Q4 		$1.1M Buy
65,778
+2,335
+4% +$44K ﹤0.01% 791
2024
Q3 		$1.46M Sell
63,443
-4,023
-6% -$86.1K ﹤0.01% 750
2024
Q2 		$1.62M Buy
67,466
+10,535
+19% +$319K ﹤0.01% 728
2024
Q1 		$1.85M Buy
+56,931
New +$2.02M ﹤0.01% 724

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Nordea Investment Management's ARCT Position: Q2 2025 in Review

Nordea Investment Management sold out of Arcturus Therapeutics (ARCT) in Q2 2025, closing a stake of 94,419 shares — an estimated $997K sold.

Nordea Investment Management first reported a position in ARCT in Q1 2024 and held it in 5 quarters. The position peaked at $1.85M in Q1 2024. 144 funds tracked by Wall St. Rank hold ARCT as of Q2 2025.

  • Nordea Investment Management reported no remaining Arcturus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Nordea Investment Management sold 94,419 Arcturus Therapeutics shares in Q2 2025, an estimated $997K.
  • Nordea Investment Management first reported a position in Arcturus Therapeutics in Q1 2024 and held it in 5 quarters.
  • Nordea Investment Management's Arcturus Therapeutics position peaked at $1.85M in Q1 2024.
  • 144 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2025.

Based on Nordea Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.